U.S. Tumor Ablation Market Size & Outlook, 2023-2030
U.S. tumor ablation market, 2018-2030 (US$M)
Related Markets
U.S. tumor ablation market highlights
- The U.S. tumor ablation market generated a revenue of USD 391.7 million in 2023 and is expected to reach USD 886.4 million by 2030.
- The U.S. market is expected to grow at a CAGR of 12.4% from 2024 to 2030.
- In terms of segment, radiofrequency ablation was the largest revenue generating technology in 2023.
- Other Ablation Technologies is the most lucrative technology segment registering the fastest growth during the forecast period.
Tumor ablation market data book summary
| Market revenue in 2023 | USD 391.7 million |
| Market revenue in 2030 | USD 886.4 million |
| Growth rate | 12.4% (CAGR from 2023 to 2030) |
| Largest segment | Radiofrequency ablation |
| Fastest growing segment | Other Ablation Technologies |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation, Other Ablation Technologies |
| Key market players worldwide | Medtronic PLC, Boston Scientific Corp, Johnson & Johnson, AngioDynamics Inc, Bioventus Inc Class A, Edap TMS SA ADR, Mermaid Medical, Chongqing Haifu Technology, HealthTronics, H.S. Hospital Service |
Other key industry trends
- In terms of revenue, U.S. accounted for 23.4% of the global tumor ablation market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. tumor ablation market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 420.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Tumor Ablation Market Scope
Tumor Ablation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. tumor ablation market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tumor ablation market will help companies and investors design strategic landscapes.
Radiofrequency ablation was the largest segment with a revenue share of 34.75% in 2023. Horizon Databook has segmented the U.S. tumor ablation market based on radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation, other ablation technologies covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. accounted for the largest share of the tumor ablation market in North America in 2022 and is expected to maintain its dominance during the forecast period. This can be attributed to high healthcare expenditure, increasing demand for tumor ablation technologies, growing incidence of cancer, and growing awareness regarding early disease diagnosis.
For instance, according to the American Cancer Society, in 2023, approximately 1,958,310 new cancer cases are expected to be diagnosed in the U.S. and approximately 609,820 patients will die due to the same.
According to the National Cancer Institute, cancer mortality rates decreased by nearly 1.8% among men and 1.4% among women. Cancer survival rate has also improved over the past few years, reflecting the quality of healthcare in the U.S., which is expected to contribute to market growth.
Reasons to subscribe to U.S. tumor ablation market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. tumor ablation market databook
-
Our clientele includes a mix of tumor ablation market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. tumor ablation market , including forecasts for subscribers. This country databook contains high-level insights into U.S. tumor ablation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. tumor ablation market size, by technology, 2018-2030 (US$M)
U.S. Tumor Ablation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
